首页> 外文期刊>Cellular immunology >A novel mimovirus encoding ChgA 10–19 peptide with PD-L1 induces T cell tolerance and ameliorates the severity of diabetes
【24h】

A novel mimovirus encoding ChgA 10–19 peptide with PD-L1 induces T cell tolerance and ameliorates the severity of diabetes

机译:编码CHGA 10-19肽的新型MIMoVirus,具有PD-L1诱导T细胞耐受性并改善糖尿病的严重程度

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? Transduced DCs attenuated CD8+ T cell activation and proliferation. ? Transduced DCs inhibited CD8+ T response to ChgA stimulation, and ameliorated the severity of diabetes. ? Mimovirus transduced DCs might provide novel clues for T1D therapy. Abstract Related studies demonstrate that type 1 diabetes (T1D) is caused by β-cell antigen specific autoreactive CD8+ T cells. ChgA has recently been identified as the autoantigen in NOD mice and T1D patients. Therefore, attenuating the activation of ChgA specific CD8+ T cells might be a promising target for T1D therapy. The negative co-stimulatory PD-L1 inhibits T cell mediated alloimmunity and induces tolerance. In this experiment, a novel mimovirus encoding ChgA 10–19 peptide with PD-L1 was constructed. The NOD.β2m null HHD mice were administrated with mimovirus transduced DCs. After immunization, the activation and proliferation of CD8+ T cells were detected, diabetes incidence and pancreatic tissue destruction were also analyzed. The results demonstrated that transduced DCs attenuated CD8+ T cell activation and proliferation. In addition, transduced DCs inhibited CD8+ T response to ChgA stimulation, and ameliorated the severity of diabetes. These data suggested that mimovirus transduced DCs might provide novel clues for T1D therapy.
机译:亮点?转导的树突状细胞减弱CD8+T细胞的活化和增殖?转导的DC抑制CD8+T对ChgA刺激的反应,并改善糖尿病的严重程度?微小病毒转导的DC可能为T1D治疗提供新线索。摘要相关研究表明,1型糖尿病(T1D)是由β细胞抗原特异性自身反应性CD8+T细胞引起的。ChgA最近被确认为NOD小鼠和T1D患者的自身抗原。因此,减弱ChgA特异性CD8+T细胞的激活可能是T1D治疗的一个有希望的靶点。负性共刺激PD-L1抑制T细胞介导的同种异体免疫并诱导耐受。在本实验中,构建了编码ChgA 10–19肽和PD-L1的新型微小病毒。点头。 免疫后检测CD8+T细胞的活化和增殖,分析糖尿病发病率和胰腺组织破坏情况。结果表明,转导的DC减弱了CD8+T细胞的活化和增殖。此外,转导的DC抑制了CD8+T对ChgA刺激的反应,并改善了糖尿病的严重程度。这些数据表明,微小病毒转导的DC可能为T1D治疗提供新的线索。

著录项

  • 来源
    《Cellular immunology》 |2017年第2017期|共6页
  • 作者单位

    Department of Outpatient The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

    Department of Obstetrics and Gynecology The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

    Department of Endocrinology and Metabolism The Third People’s Hospital of Linyi;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

    Mimovirus; ChgA10–19; PD-L1; T cell tolerance; Diabetes;

    机译:Mimovirus;CHGA10-19;PD-L1;T细胞耐受性;糖尿病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号